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Probable Person-to-Person Transmission of Legionnaires’ 
Disease
To the Editor: Legionnaires’ disease is an of-
ten severe form of pneumonia that is typically 
acquired by susceptible persons (e.g., elderly 
persons and smokers) through inhalation of 
aerosols that contain legionella species.1-4 A clus-
ter of cases of this disease occurred in Vila 
Franca de Xira, Portugal, in 2014.5
One of the first cases of disease in this clus-
ter occurred in a 48-year-old man (Patient 1), a 
smoker, who had been employed since October 
6, 2014, as a maintenance worker at an indus-
trial cooling tower complex in Vila Franca de 
Xira that was subsequently found to be contami-
nated with Legionella pneumophila.5 He returned to 
the home that he shared with is mother in Porto 
(approximately 300 km from Vila Franca de 
Xira) on October 11 and again on the evening 
of October 19 (Fig. 1). His symptoms began on 
October 14, and on October 19, he had severe 
respiratory symptoms, including an intense cough. 
During that night, his mother (Patient 2) took 
care of him until he was admitted to the hospi-
tal (Centro Hospitalar do Porto) approximately 
8 hours later. On October 22, he was transferred 
to another hospital to receive extracorporeal 
membrane oxygenation.
On October 27, Patient 2, who was a previ-
ously healthy 74-year-old woman, began to report 
fever, cough, and loss of appetite. She was ad-
mitted to the same hospital on November 3 with 
septic shock due to pneumonia, and she died on 
December 1. Patient 1 died on January 7, 2015.
Urine specimens obtained from both patients 
showed positive results on testing for legionella 
antigens with the use of a commercial enzyme 
immunoassay (Binax), and legionella was grown 
in culture from respiratory secretions. L. pneu-
mophila serogroup 1 was identified, and strains 
were sent to the National Institute of Health in 
Lisbon for sequence-based typing and whole-
genome sequencing (details are provided in the 
Methods section in the Supplementary Appen-
dix, available with the full text of this letter at 
NEJM.org). Samples from the patients were ob-
tained and processed more than 2 weeks apart 
(for culture and sequence-based typing) and 
4 weeks apart (for whole-genome sequencing) to 
minimize the risk of cross-contamination. Both 
strains showed the novel ST1905 profile (identi-
fied as the causative strain in the cluster5), and 
whole-genome sequencing revealed no nucleo-
tide differences within the region that spanned 
approximately 3.47 Mb of the genome sequence. 
This genome matched the one identified in the 
cluster-related isolates.
An investigation headed by the General Direc-
torate of Health showed that L. pneumophila 
ST1905–associated disease occurred in people 
who lived or stayed in Vila Franca de Xira be-
tween October 14, when the cluster began, and 
November 21, when it was considered to be 
controlled. Patient 2 had remained in Porto dur-
ing these months, and to the best of our knowl-
edge, she was the only person infected with 
L. pneumophila ST1905 who was not geographi-
cally linked to the cluster epicenter. Later inves-
tigation revealed that Patient 2 had never been to 
Vila Franca de Xira, and during the cluster period, 
Figure 1. Timeline of Probable Transmission of Legionnaires’ Disease from Patient 1 to Patient 2.
ECMO denotes extracorporeal membrane oxygenation.
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no additional cases of Legionnaires’ disease oc-
curred in Porto.
Patients 1 and 2 lived alone in Porto, and 
their house consisted of small nonventilated 
rooms without air-conditioning units or room 
humidifiers. Collected water samples from the 
bathroom and the kitchen and a swab of the 
shower drain were negative for legionella. Pa-
tient 1 did not take water from Vila Franca de 
Xira to Porto.
We suspect that person-to-person transmis-
sion probably occurred when Patient 2 cared for 
her severely ill son. Factors that suggest person-
to-person transmission are the severity of the 
respiratory symptoms in Patient 1, the very close 
contact that occurred during the 8 consecutive 
hours when Patient 2 took care of Patient 1, and 
the small area of the nonventilated room where 
this contact took place. In addition, the timeline 
of the events was highly coherent (i.e., the symp-
toms in Patient 2 developed 1 week after the 
close contact with Patient 1; this is consistent 
with the typical incubation period of Legion-
naires’ disease — a median of 6 to 7 days).1
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